"Hypercholesterolemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
Descriptor ID |
D006937
|
MeSH Number(s) |
C18.452.584.500.500.396
|
Concept/Terms |
Hypercholesterolemia- Hypercholesterolemia
- Hypercholesterolemias
- High Cholesterol Levels
- Cholesterol Level, High
- Cholesterol Levels, High
- High Cholesterol Level
- Level, High Cholesterol
- Levels, High Cholesterol
- Elevated Cholesterol
- Cholesterol, Elevated
- Cholesterols, Elevated
- Elevated Cholesterols
- Hypercholesteremia
- Hypercholesteremias
|
Below are MeSH descriptors whose meaning is more general than "Hypercholesterolemia".
Below are MeSH descriptors whose meaning is more specific than "Hypercholesterolemia".
This graph shows the total number of publications written about "Hypercholesterolemia" by people in this website by year, and whether "Hypercholesterolemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 1 | 1 |
1994 | 2 | 0 | 2 |
1995 | 3 | 0 | 3 |
1996 | 4 | 0 | 4 |
1997 | 3 | 1 | 4 |
1998 | 4 | 0 | 4 |
1999 | 5 | 0 | 5 |
2000 | 8 | 1 | 9 |
2001 | 10 | 3 | 13 |
2002 | 6 | 1 | 7 |
2003 | 11 | 1 | 12 |
2004 | 2 | 1 | 3 |
2005 | 7 | 3 | 10 |
2006 | 8 | 3 | 11 |
2007 | 4 | 1 | 5 |
2008 | 6 | 0 | 6 |
2009 | 8 | 3 | 11 |
2010 | 2 | 2 | 4 |
2011 | 4 | 2 | 6 |
2012 | 2 | 0 | 2 |
2013 | 4 | 2 | 6 |
2014 | 2 | 1 | 3 |
2015 | 0 | 1 | 1 |
2016 | 2 | 0 | 2 |
2017 | 3 | 1 | 4 |
2018 | 4 | 2 | 6 |
2019 | 1 | 0 | 1 |
2020 | 0 | 2 | 2 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypercholesterolemia" by people in Profiles.
-
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy. J Cancer Surviv. 2023 Feb; 17(1):27-39.
-
Targeting PCSK9 inhibitors to those who will benefit most. Lancet Diabetes Endocrinol. 2022 05; 10(5):301-303.
-
Pig and Mouse Models of Hyperlipidemia and Atherosclerosis. Methods Mol Biol. 2022; 2419:379-411.
-
Levothyroxine treatment and cholesterol in hypothyroidism. Nat Rev Endocrinol. 2020 04; 16(4):193-194.
-
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9. BioDrugs. 2020 Feb; 34(1):1-9.
-
Management of Blood Cholesterol. JAMA. 2019 02 26; 321(8):800-801.
-
Increasing Stroke Knowledge and Decreasing Stroke Risk in a Latino Immigrant Population. J Immigr Minor Health. 2018 Dec; 20(6):1490-1499.
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):3210-3227.
-
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. J Am Heart Assoc. 2018 09 18; 7(18):e009221.
-
Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K+ Channels. J Am Heart Assoc. 2018 03 03; 7(5).